Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0001415889-24-023791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-20 | 2024-09-18 | GPCR | Coll Crespo Blas | Chief Medical Off | A - Grant | $0.00 | +90.6K | 102.6K | +755% | $0 |
| D | 2024-09-20 | 2024-09-18 | GPCR | Coll Crespo Blas | Chief Medical Off | A - Grant | $0.00 | +111.0K | 111.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-09-18 | A | A | 90,600 | $0.00 | 102,600 | D | — | — | (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. (F2) Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan. |
| 2 | Derivative | Share option (right to buy) | 2024-09-18 | A | A | 111,000 | $0.00 | 111,000 | D | $12.75 · — to 2034-09-17 | 111,000 Ordinary Shares | (F3) The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. (F4) One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. |